CLINICAL_TRIALS
trial_result
· 2021-03-08
Clinical Trial Update: A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients [Phase 1]
Summary
Phase I trial update of OCV-501 in acute myeloid leukemia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2021-03-08